Guest: Stephen B. Baylin, MD <br>

  Host: Leslie P. Lundt, MD <br>


  
    <p>The Cancer Genome Atlas (TCGA) has recently reported results from its first comprehensive study focusing on glioblastoma multiforme. How might this new research help us develop new therapies? Dr. Stephen Baylin, professor of oncology and medicine at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, joins host Dr. Leslie Lundt to explain how the TCGA may guide future cancer treatment.</p>

Guest: Stephen B. Baylin, MD Host: Leslie P. Lundt, MD The Cancer Genome Atlas (TCGA) has recently reported results from its first comprehensive study focusing on glioblastoma multiforme. How might this new research help us develop new therapies? Dr. Stephen Baylin, professor of oncology and medicine at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, joins host Dr. Leslie Lundt to explain how the TCGA may guide future cancer treatment.

Developing New Therapies to Treat Glioblastoma

According to the American Cancer Society, yearly deaths from cancer are decreasing— marking the first period of decline in nearly 70 years. ReachMD takes a closer look at the driving forces behind these advances: medications that hone in on specific tumor targets, more accurate screening and diagnostic technologies, and pioneering surgical methods that provide new hope for patients suffering from these devastating diseases.

Share Developing New Therapies to Treat Glioblastoma

Sign up to save your podcasts

Developing New Therapies to Treat Glioblastoma

Developing New Therapies to Treat Glioblastoma